Invention Grant
- Patent Title: Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
- Patent Title (中): 用抗增生和抗炎药治疗哮喘和慢性阻塞性肺疾病
-
Application No.: US13903379Application Date: 2013-05-28
-
Publication No.: US09402935B2Publication Date: 2016-08-02
- Inventor: Lixiao Wang
- Applicant: Lutonix, Inc.
- Applicant Address: US MN New Hope
- Assignee: Lutonix, Inc.
- Current Assignee: Lutonix, Inc.
- Current Assignee Address: US MN New Hope
- Agency: Dinsmore & Shohl
- Main IPC: A61F13/00
- IPC: A61F13/00 ; A61M31/00 ; A61L29/16 ; A61K31/337 ; A61K31/436 ; A61L31/16 ; A61L29/08 ; A61M25/10 ; A61K9/00

Abstract:
Embodiments of the present invention provide a method for treatment of respiratory disorders such as asthma, chronic obstructive pulmonary disease, and chronic sinusitis, including cystic fibrosis, interstitial fibrosis, chronic bronchitis, emphysema, bronchopulmonary dysplasia and neoplasia. The method involves administration, preferably oral, nasal or pulmonary administration, of anti-inflammatory and anti-proliferative drugs (rapamycin or paclitaxel and their analogs) and an additive.
Public/Granted literature
Information query